1. Home
  2. PRZO vs ICCM Comparison

PRZO vs ICCM Comparison

Compare PRZO & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ParaZero Technologies Ltd.

PRZO

ParaZero Technologies Ltd.

HOLD

Current Price

$0.51

Market Cap

18.6M

Sector

N/A

ML Signal

HOLD

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$3.59

Market Cap

20.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRZO
ICCM
Founded
2014
2006
Country
Israel
Israel
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
18.6M
20.4M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
PRZO
ICCM
Price
$0.51
$3.59
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
430.7K
8.8M
Earning Date
03-26-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$139.51
Revenue Next Year
N/A
$75.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$0.13
52 Week High
$2.15
$9.54

Technical Indicators

Market Signals
Indicator
PRZO
ICCM
Relative Strength Index (RSI) 44.88 46.80
Support Level $0.45 $0.48
Resistance Level $0.57 $5.69
Average True Range (ATR) 0.04 0.61
MACD 0.01 -0.39
Stochastic Oscillator 50.08 2.66

Price Performance

Historical Comparison
PRZO
ICCM

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd operates as an aerospace defense company focused on the development of smart, autonomous solutions for the manned and unmanned aerial systems (UAS) industry. The Company develops, manufactures, markets, and sells counter-UAS net-launching platforms designed to protect against hostile drones in both battlefield and urban environments, precision aerial delivery systems for military applications, and smart, autonomous parachute safety systems designed to enable safe flight operations over populated areas and beyond visual line-of-sight. The Company sells its products internationally.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: